Search

everythinglearnresearchcommunity

for

Search:↓

Herpes gestationis is linked to certain antigens, atopic eczema affects T cell populations and may be eased by breastfeeding, higher doses of anti-androgen treatment can improve androgenic alopecia, topical minoxidil increases hair thickness, long-term methotrexate therapy can cause liver fibrosis in psoriasis patients, and Lichen Sclerosus et Atrophicus patients aren't at higher risk for autoimmune disorders.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Lichen planus pigmentosus causes dark skin patches and is treated by avoiding triggers and using anti-inflammatory medications.

New genetic discoveries may lead to better treatments for alopecia areata.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

New treatments for alopecia areata may target specific immune cells and pathways involved in hair loss.

A man's skin condition, pemphigus vulgaris, came back after he was treated with interleukin 2 for cancer.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Genetic discoveries are leading to new treatments for alopecia areata.

The review concludes that accurate diagnosis of different types of hair loss requires proper biopsy techniques and understanding the hair growth cycle and underlying causes.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

People with Lichen planopilaris are more likely to have certain autoimmune and endocrine disorders but less likely to have conditions like allergies and diabetes.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

White hair regrowth in alopecia areata may be more common than thought.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Most skin conditions in Down syndrome are benign and involve dry or thickened skin.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Autoimmunity can cause both alopecia areata and idiopathic primary hypophysitis.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.